AAAAAA
Results: 1-25/27
Authors:
Legro, RS
Citation: Rs. Legro, Diabetes prevalence and risk factors in polycystic ovary syndrome, OB GYN CLIN, 28(1), 2001, pp. 99
Authors:
Legro, RS
Citation: Rs. Legro, Polycystic Ovary Syndrome: the new millenium, MOL C ENDOC, 184(1-2), 2001, pp. 87-93
Authors:
Azziz, R
Ehrmann, D
Legro, RS
Whitcomb, RW
Hanley, R
Fereshetian, AG
O'Keefe, M
Ghazzi, MN
Citation: R. Azziz et al., Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: A multicenter, double blind, placebo-controlled trial, J CLIN END, 86(4), 2001, pp. 1626-1632
Authors:
Vgontzas, AN
Legro, RS
Bixler, EO
Grayev, A
Kales, A
Chrousos, GP
Citation: An. Vgontzas et al., Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: Role of insulin resistance, J CLIN END, 86(2), 2001, pp. 517-520
Authors:
Azziz, R
Ehrmann, D
Legro, RS
Whitcomb, R
Hanley, R
Fereshtian, AG
O'Keefe, M
Ghazzi, MN
Citation: R. Azziz et al., Troglitazone use in polycystic ovary syndrome - Response, J CLIN END, 86(10), 2001, pp. 5090-5091
Authors:
Bennett, RA
Dodson, WC
Olt, GJ
Ahearn, J
Legro, RS
Citation: Ra. Bennett et al., Spontaneous conception in the presence of stage IIIC endometrioid ovarian cancer, FERT STERIL, 75(3), 2001, pp. 623-624
Authors:
Legro, RS
Kunselman, AR
Miller, SA
Satyaswaroop, PG
Citation: Rs. Legro et al., Role of androgens in the growth of endometrial carcinoma: An in vivo animal model, AM J OBST G, 184(3), 2001, pp. 303-308
Authors:
Legro, RS
Citation: Rs. Legro, Is there a male phenotype in polycystic ovary syndrome families?, J PED END M, 13, 2000, pp. 1307-1309
Authors:
Urbanek, M
Legro, RS
Driscoll, D
Strauss, JF
Dunaif, A
Spielman, RS
Citation: M. Urbanek et al., Searching for the polycystic ovary syndrome genes, J PED END M, 13, 2000, pp. 1311-1313
Authors:
Coulson, CC
Kunselman, AR
Cain, J
Legro, RS
Citation: Cc. Coulson et al., The mentor effect in student evaluation, OBSTET GYN, 95(4), 2000, pp. 619-622
Authors:
Wickenheisser, JK
Quinn, PG
Nelson, VL
Legro, RS
Strauss, JF
McAllister, JM
Citation: Jk. Wickenheisser et al., Differential activity of the cytochrome P450 17 alpha-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells, J CLIN END, 85(6), 2000, pp. 2304-2311
Authors:
Legro, RS
Lin, HM
Demers, LM
Lloyd, T
Citation: Rs. Legro et al., Rapid maturation of the reproductive axis during perimenarche independent of body composition, J CLIN END, 85(3), 2000, pp. 1021-1025
Authors:
Urbanek, M
Wu, XQ
Vickery, KR
Kao, LC
Christenson, LK
Schneyer, A
Legro, RS
Driscoll, DA
Strauss, JF
Dunaif, A
Spielman, RS
Citation: M. Urbanek et al., Allelic variants of the follistatin gene in polycystic ovary syndrome, J CLIN END, 85(12), 2000, pp. 4455-4461
Authors:
Lloyd, T
Taylor, DS
Lin, HM
Matthews, AE
Eggli, DF
Legro, RS
Citation: T. Lloyd et al., Oral contraceptive use by teenage women does not affect peak bone mass: a longitudinal study, FERT STERIL, 74(4), 2000, pp. 734-738
Authors:
Comings, DE
Blake, H
Dietz, G
Gade-Andavolu, R
Legro, RS
Saucier, G
Johnson, P
Verde, R
MacMurray, JP
Citation: De. Comings et al., The proenkephalin gene (PENK) and opioid dependence, NEUROREPORT, 10(5), 1999, pp. 1133-1135
Authors:
Legro, RS
Citation: Rs. Legro, Polycystic ovary syndrome - Phenotype to genotype, END METAB C, 28(2), 1999, pp. 379
Authors:
Nelson, VL
Legro, RS
Strauss, JF
McAllister, JM
Citation: Vl. Nelson et al., Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries, MOL ENDOCR, 13(6), 1999, pp. 946-957
Authors:
Legro, RS
Gnatuk, CL
Kunselman, AR
Cain, J
Citation: Rs. Legro et al., Oocyte donors as gynecologic teaching associates, OBSTET GYN, 93(1), 1999, pp. 147-150
Authors:
Urbanek, M
Legro, RS
Driscoll, DA
Azziz, R
Ehrmann, DA
Norman, RJ
Strauss, JF
Spielman, RS
Dunaif, A
Citation: M. Urbanek et al., Thirty-seven candidate genes for polycystic ovary syndrome: Strongest evidence for linkage is with follistatin, P NAS US, 96(15), 1999, pp. 8573-8578
Authors:
Dunaif, A
Legro, RS
Citation: A. Dunaif et Rs. Legro, Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome - Authors' response, J CLIN END, 84(8), 1999, pp. 2975-2976
Authors:
Legro, RS
Kunselman, AR
Dodson, WC
Dunaif, A
Citation: Rs. Legro et al., Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlledstudy in 254 affected women, J CLIN END, 84(1), 1999, pp. 165-169
Authors:
Legro, RS
Dunaif, A
Citation: Rs. Legro et A. Dunaif, Fasting glucose to insulin ratio, or product of glucose and insulin? Authors' response, J CLIN END, 84(1), 1999, pp. 383-383
Authors:
Legro, RS
Blanche, P
Krauss, RM
Lobo, RA
Citation: Rs. Legro et al., Alterations in low-density lipoprotein and high-density lipoprotein subclasses among Hispanic women with polycystic ovary syndrome: influence of insulin and genetic factors, FERT STERIL, 72(6), 1999, pp. 990-995
Authors:
Good, C
Tuchinsky, M
Mauger, D
Demers, LM
Legro, RS
Citation: C. Good et al., Bane mineral density and body composition in lean women with polycystic ovary syndrome, FERT STERIL, 72(1), 1999, pp. 21-25
Authors:
Legro, RS
Citation: Rs. Legro, Insulin resistance in polycystic ovary syndrome: treating a phenotype without a genotype, MOL C ENDOC, 145(1-2), 1998, pp. 103-110